Navigation Links
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Date:2/1/2010

l after one year.(2) (3) Vascugel may represent a fundamentally new approach to preventing AV access failure by helping to regulate the body's healing response following the creation of an AV access site.

This news release contains certain forward-looking statements that involve risks and uncertainties. Such statements are only predictions and the company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may cause such differences include the timing of clinical trials, the risk that products that appeared promising in early research and clinical trials do not demonstrate safety or efficacy in clinical trials and the risk that the company will not obtain approval to market its products.

(1) http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/index.htm. Last accessed January 27, 2010.

(2) Dixon et al. DAC Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009; 360: 2191-2201.

(3) Hayashi et al. Vascular access for hemodialysis. Nat Clin Pract Nephrol. 2006; 2: 504-513.

    
    
    Company Contact:
    Margaret O'Toole
    Pervasis Therapeutics, Inc.
    617-871-1201
    
    Media Contact: 
    Jaren Irene Madden
    Feinstein Kean Healthcare
    617-761-6727

SOURCE Pervasis Therapeutics, Inc.

RELATED LINKS
http://www.pervasistx.com

'/>"/>

SOURCE Pervasis Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)...  AnaptysBio, Inc., a leader in the discovery ... appointment of Marco Londei , M.D. as ... preclinical and clinical development of AnaptysBio,s proprietary antibody ... welcome Dr. Londei to AnaptysBio,s executive leadership team," ... Executive Officer of AnaptysBio. "Dr. Londei,s extensive expertise ...
(Date:10/20/2014)... 20, 2014 Pharmaceutic Labs announces the opening ... Albany, NY for admixing, compounding, drug ... and/or exceeds the FDA standards for safety and quality, ... 211. The 10,000 square foot outsourcing ... quality assurance and quality control. The company will produce ...
(Date:10/20/2014)... and RALEIGH, N.C., Oct. 20, 2014 /PRNewswire/ ... Neuropathy Foundation (HNF), both philanthropies, announced today the ... candidates for the treatment of the rare disease ... BioPontis Alliance announced its alliance model earlier this ... first demonstration of a collaborative model where researchers ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3
(Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... October 19, 2014 Dr. Babatunde Osotimehin, ... welcomes news of a ceasefire agreement that is expected ... 200 girls who were kidnapped from the north-eastern Nigerian ... in captivity long enough, and it is high time ... stated Dr. Osotimehin. , "We owe it to these ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
(Date:10/19/2014)... 19, 2014 (HealthDay News) -- New stem cell-based research ... to new treatments, a new study suggests. Scientists ... intestinal tissue in a lab dish. They then transplanted ... studying intestinal disorders, according to the researchers. "This ... and conditions that can cause intestinal failure, from genetic ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... at risk of suffering broken bones, torn ligaments, arthritis ... pet, there are veterinarians who can treat these ... Roush, an orthopedic surgeon at the Veterinary Medical Teaching ... ,Roush frequently performs orthopedic surgeries on small ...
... The research by a team of Emory University scientists ... altered by genetic mutations recently identified in Parkinson disease development. ... function and could provide a target for drug therapies to ... disorder of the central nervous system resulting from the loss ...
... highest level of health boosting antioxidants which could protect ... to cancer -- shows latest research. ,Blackcurrant ... and northern Europe and northern Asia. Scientists have found ... than other fruits like apples, strawberries, mangoes or bananas. ...
... show that women with diabetes are still in a high ... death rate. All the advances in medical science have reduced ... sadly it does not seem to apply to women ... men with diabetes has dropped dramatically over the last few ...
... Medicine shows that men can help avoid fractures if ... are common among older people and can have devastating consequences, ... that women should take exercise to reduce the thinning ... age is known as osteoporosis. Women are at particular risk ...
... ban on the use of plastic and polythene materials to ... before flooded Guwahati, throwing the city out of gear ... the use of plastic and polythene is one of the ... be enforced very strictly and there would be penalties like ...
Cached Medicine News:Health News:Some Common Human Injuries Also Common in Dogs 2Health News:Some Common Human Injuries Also Common in Dogs 3Health News:Parkinsons Disease Protein Pathway Identified 2Health News:Diabetic Womens Death Rate Shows No Decline 2Health News:Exercise Reduces Fracture in Men 2
Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen....
... Microtome has a look that is revolutionary, a ... functions and capabilities that will please the most ... experience and knowledge but still breaking new ground ... will be the answer to many of your ...
Clock oil, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Medicine Products: